Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

Sarah B. Goldberg, Kurt A. Schalper, Scott Gettinger, +21

The Lancet Oncology

Neuro-oncologyPrognostic BiomarkersBiomarker AnalysisBrain MetastasesMedicine +9

Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial

Harriet M. Kluger, Veronica Chiang, Amit Mahajan, +14

Journal of Clinical Oncology

Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma

Pok Fai Wong, Wei Wei, James W. Smithy, +6

Clinical Cancer Research

Methods for Analysis of Pre-Post Data in Clinical Research: A Comparison of Five Common Methods

Nathaniel S. O’Connell, Lin Dai, Yunyun Jiang, +5

Journal of Biometrics & Biostatistics

Clinical SpecialtiesTreatment EffectPost Treatment MeasurementPrehabilitationRandomized Controlled Trial +17

Role of the Indirect Pathway of the Basal Ganglia in Perceptual Decision Making

Wei Wei, Jonathan E. Rubin, Xiao‐Jing Wang

Journal of Neuroscience

A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non–Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1

Sarah A. Weiss, Dijana Djureinovic, Shlomit Jessel, +19

Clinical Cancer Research

Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study

Maximilian Stahl, Rory M. Shallis, Wei Wei, +32

Leukemia

Hematological MalignancyMedicineAcute Myeloid LeukemiaLong-term Clinical OutcomesHematology +7

Type 3 Inositol 1,4,5‐Trisphosphate Receptor Is Increased and Enhances Malignant Properties in Cholangiocarcinoma

Pimwipa Ueasilamongkol, Tanaporn Khamphaya, Mateus T. Guerra, +12

Hepatology

Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma

Pok Fai Wong, Wei Wei, Swati Gupta, +4

Journal for ImmunoTherapy of Cancer

Loss of MLL PHD Finger 3 Is Necessary for MLL-ENL–Induced Hematopoietic Stem Cell Immortalization

Jing Chen, Donna A. Santillan, Mark Koonce, +5

Cancer Research